Latarjet Procedure vs Anatomic Glenoid Reconstruction for Shoulder Dislocation
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial compares two surgical procedures, Latarjet and Anatomic Glenoid Reconstruction (AGR), for treating recurring shoulder dislocations. Both procedures aim to repair the glenoid bone, potentially reducing future dislocations, alleviating pain, and enhancing shoulder function. The trial evaluates the outcomes of these surgeries to determine which is more effective and has fewer complications. Individuals with one or more anterior shoulder dislocations and significant bone loss in the shoulder may qualify for this trial. As an unphased trial, it provides patients the chance to contribute to valuable research that could enhance surgical outcomes for future patients.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that these surgical procedures are safe for shoulder dislocation treatment?
Research has shown that the Latarjet procedure is generally safe for individuals with shoulder instability. Most patients experience improved shoulder function and stability, with many returning to sports post-surgery. A long-term study found that 86.8% to 93.5% of patients achieved good to excellent results years later.
Studies on Anatomic Glenoid Reconstruction (AGR) also demonstrate its safety. This procedure has a safety record comparable to the Bankart repair, another common shoulder surgery. No reported cases of recurrent shoulder dislocation after AGR surgery indicate a strong safety record.
Both surgeries are well-tolerated, reducing shoulder dislocations while improving function and reducing pain. Overall, both procedures are safe options for treating shoulder instability.12345Why are researchers excited about this trial?
Researchers are excited about the Latarjet procedure and Anatomic Glenoid Reconstruction for shoulder dislocations because they offer new surgical techniques to enhance joint stability. The Latarjet procedure uses an autograft to reinforce the glenoid, potentially providing improved strength and lessening the chance of recurrent dislocations. In contrast, the Anatomic Glenoid Reconstruction uses an allograft, which might offer better anatomical restoration of the shoulder joint, possibly leading to more natural joint function. These approaches aim to address the limitations of traditional surgeries like Bankart repair by offering potentially better outcomes for patients.
What evidence suggests that this trial's treatments could be effective for shoulder dislocation?
This trial will compare the Latarjet procedure with Anatomic Glenoid Reconstruction (AGR) for treating shoulder instability. Studies have shown that the Latarjet procedure effectively treats shoulder instability by using a piece of bone to stabilize the shoulder joint, reducing the risk of dislocation. This method is considered a top choice due to its consistently good long-term results. In contrast, AGR is a newer technique gaining attention. It also uses bone to rebuild the shoulder joint but in a slightly different manner. Early research suggests that AGR is safe and effective, with a low risk of complications and recurrent dislocation. Both treatments in this trial aim to reduce pain and prevent future dislocations.14678
Who Is on the Research Team?
Ivan Wong, MD
Principal Investigator
Nova Scotia Health Authority, Orthopaedic Surgeon
Are You a Good Fit for This Trial?
This trial is for individuals who have experienced one or more anterior shoulder dislocations and show over 20% bone loss on a pre-operative CT scan. It's not suitable for those with posterior or multidirectional instability, massive rotator cuff tears, substance abuse history, or inability to consent or accept random treatment assignment.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo either the Latarjet or Anatomic Glenoid Reconstruction surgical procedure to address anterior shoulder instability with glenoid bone loss
Follow-up
Participants are monitored for safety, complications, and effectiveness of the surgical intervention through clinical and radiographic outcome measures
Long-term follow-up
Participants continue to be monitored for recurrent instability and other long-term outcomes
What Are the Treatments Tested in This Trial?
Interventions
- Anatomic Glenoid Reconstruction
- Latarjet
Anatomic Glenoid Reconstruction is already approved in European Union, United States for the following indications:
- Anterior shoulder instability
- Glenoid bone loss
- Recurrent shoulder dislocations
- Glenoid bone loss
Find a Clinic Near You
Who Is Running the Clinical Trial?
Nova Scotia Health Authority
Lead Sponsor